@BiotechTV

Daily biotech news, content, and exclusive interviews.

 Kendall Square
biotechtv.com/
Joined May 2023
  • Tweets2.8K
  • Following44
  • Followers12.2K
2.5KMedia
๐…๐ซ๐จ๐ฆ ๐๐˜๐’๐„: @Mizuho Senior Biotech Analyst @salimqsyed shares his take on biotech's current lull, and discusses companies he covers. $XBI $RCUS $CYTK $BBIO $MAZE $IPSC Full video: biotechtv.com/post/salim-syeโ€ฆ
2
2
24
4,057
๐…๐ซ๐จ๐ฆ ๐๐˜๐’๐„: @Immuneering Co-Founder & CEO @BenZeskind discusses the future of the third generation MEK inhibitor atebimetinib, which has shown promising data in first line pancreatic cancer. $IMRX Full video: biotechtv.com/post/immuneeriโ€ฆ
5
1,401
๐…๐ซ๐จ๐ฆ ๐๐˜๐’๐„: @BarclaysCIB Biotech Analyst Ellie Merle previews this weekend's highly anticipated cancer vaccine data from Merck and Moderna at ESMO. She sees scenarios for the stock ranging from $100 to mid $400's. $MRK $MRNA Full video: biotechtv.com/post/ellie-merโ€ฆ
3
2
4
31
15,782
๐…๐ซ๐จ๐ฆ ๐๐˜๐’๐„: Lexeo Therapeutics' CEO Nolan Townsend discusses a recent acquisition in Friedreich's ataxia and upcoming data in PKP2 arrhythmogenic cardiomyopathy. $LXEO Full video: biotechtv.com/post/lexeo-theโ€ฆ
1
3
11
3,041
๐…๐ซ๐จ๐ฆ ๐๐˜๐’๐„: BiotechTV will be at the iconic @NYSE today. Watch for these interviews this afternoon. $LXEO $IMRX
1
8
1,340
๐‚๐จ๐ง๐ ๐ซ๐š๐ญ๐ฎ๐ฅ๐š๐ญ๐ข๐จ๐ง๐ฌ ๐Ž๐ซ๐œ๐ก๐ž๐ฌ๐ญ๐ซ๐š: Congratulations to our sponsor and partner Orchestra - it was announced moments ago that they are being acquired by @OpenAI. Kudos to @ashokaraj_ and the entire Orchestra team!
2
8
21
2,799
BiotechTV retweeted
Brad Loncar
@bradloncarOct 20
Iโ€™m very happy for @ashokaraj_ and the Orchestra team. It has been an honor working with them this year as a sponsor partner to @BiotechTV, and learning from the best how AI and agents are transforming biopharma. Very smart move by @OpenAI!
Ashoka Rajendra
@ashokaraj_Oct 20
Four years ago to the day, we started Orchestra Bio to help biotech and pharma teams advance their drug development programs. AI has now reached an inflection point where people and agents can take this on together. Today, weโ€™re thrilled to share that Orchestra Bio is joining OpenAI to continue our mission at an even greater scale.
6
5
48
6,666
๐‚๐จ๐ฆ๐ฉ๐š๐ง๐ฒ ๐๐ž๐ฐ๐ฌ: Penn spin-out Incuta Therapeutics is developing a long-lasting JAK inhibitor for hidradenitis suppurativa that is designed to concentrate at the site of the lesions. Full video: biotechtv.com/post/incuta-thโ€ฆ
1
4
1,422
๐๐ข๐จ๐ญ๐ž๐œ๐ก ๐‚๐„๐Ž ๐’๐ข๐ฌ๐ญ๐ž๐ซ๐ก๐จ๐จ๐: Biotech company chair, director, and former CEO Paula Soteropoulos discusses learnings from her career and announces a new book she and her daughter wrote about women's health. Watch the full discussion: biotechtv.com/post/biotech-cโ€ฆ
1
5
1,427
๐๐ข๐จ๐•๐ž๐ง๐ญ๐ฎ๐ซ๐ž ๐•๐จ๐ข๐‚๐ž๐ฌ: Episode 50 | @ThirdRockV's Bob Tepper describes working in biotech (Cell Genesys & Millennium) in the early days of the sector, and Third Rock's unique culture. Watch the full episode: biotechtv.com/post/bioventurโ€ฆ
1
7
2,358
๐‚๐จ๐ฆ๐ฉ๐š๐ง๐ฒ ๐๐ž๐ฐ๐ฌ: London based IMU Biosciences announced today that it will use its immune system profiling platform with 80,000 blood samples from UK Biobank to create a large-scale picture of the human immune system. Full video: biotechtv.com/post/imu-bioscโ€ฆ
2
7
1,673
๐‚๐จ๐ฆ๐ฉ๐š๐ง๐ฒ ๐๐ž๐ฐ๐ฌ: Nouscom announced a $135M series D raise this morning. It will help the company advance through a registration study its cancer vaccine that is meant to prevent the occurrence of Lynch Syndrome in genetic carriers.
2
3
8
1,874
๐–๐ž๐ž๐ค ๐ข๐ง ๐‘๐ž๐ฏ๐ข๐ž๐ฐ: XBI was down over 6% this week. $GUTS $CTNM $VTRS $IBRX $BNTX $ABBV
1
9
1,816
๐๐ž๐ฎ๐ซ๐จ๐ฅ๐จ๐ ๐ฒ ๐ˆ๐ง๐ง๐จ๐ฏ๐š๐ญ๐ข๐จ๐ง ๐ƒ๐š๐ฒ: @NrgTherapeutics recently announced the target of its lead ALS program, NLRX1. Co-Founder and CEO Neil Miller describes it and discusses neurology drug development.
2
5
1,514
๐€๐ฅ๐ข๐ ๐ง ๐’๐ฎ๐ฆ๐ฆ๐ข๐ญ ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ”: @generaloncology was born from a family's effort to come up with something new for a woman with pancreatic cancer. Full video: biotechtv.com/post/align-sumโ€ฆ
2
4
1,361
๐€๐ฅ๐ข๐ ๐ง ๐’๐ฎ๐ฆ๐ฆ๐ข๐ญ ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ”: @ReleviumMed is developing what it believes is the first TRPV1 agonist that mitigates the burning tolerability issue seen with others in the past. Full video: biotechtv.com/post/align-sumโ€ฆ
2
5
1,357
๐๐ž๐ฎ๐ซ๐จ๐ฅ๐จ๐ ๐ฒ ๐ˆ๐ง๐ง๐จ๐ฏ๐š๐ญ๐ข๐จ๐ง ๐ƒ๐š๐ฒ: Target and biomarker discovery company @PrimaMente earned an investment from @nvidia. Co-Founder @HannahMadan describes what it means for them.
2
5
1,392
๐€๐ฅ๐ข๐ ๐ง ๐’๐ฎ๐ฆ๐ฆ๐ข๐ญ ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ”: Calluna Pharma has a S100A4 (a DAMP) targeting program currently in phase 2 for IPF that will read out in Q1 2027. Full video: biotechtv.com/post/align-sumโ€ฆ
2
6
1,558
๐๐ž๐ฎ๐ซ๐จ๐ฅ๐จ๐ ๐ฒ ๐ˆ๐ง๐ง๐จ๐ฏ๐š๐ญ๐ข๐จ๐ง ๐ƒ๐š๐ฒ: @Jack_O_Meara discusses the latest advances we have been seeing in neurology, and shares an update on his company @aerskatx.
5
1
9
2,358
๐€๐ฅ๐ข๐ ๐ง ๐’๐ฎ๐ฆ๐ฆ๐ข๐ญ: NeuroSkye Therapeutics Inc. is focused on getting medicines more efficiently across the blood-brain-barrier - both through its proprietary model and through a peptide based shuttle. Full video: biotechtv.com/post/align-sumโ€ฆ
1
3
1,276
Load more